Axsome Therapeutics, Inc.

AXSM · Nasdaq · SIC 2834: Pharmaceutical Preparations
295
SEC Filings

Business Summary

for a summary of our marketed products and clinical development programs. Since our incorporation in January 2012, our operations to date have included organizing and staffing our company, business planning, raising capital, developing our compounds, engaging in other discovery and preclinical activities, the commercial launches of AUVELITY and SUNOSI, and preparatory activities for the launch of SYMBRAVO. Subsequent to our IPO, we financed our operations primarily through proceeds from sales of...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAXSMdiscussed_in_filing Cybersecurity
topic_mentionAXSMdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001193125-26-064267EDGAR107K words
2025-02-182024-12-310000950170-25-022457EDGAR—
2024-02-232023-12-310000950170-24-019118EDGAR—
2023-02-282022-12-310000950170-23-004728EDGAR—
2022-03-012021-12-310000950170-22-002568EDGAR—
2021-03-012020-12-310001564590-21-009924EDGAR—
2020-03-122019-12-310001558370-20-002573EDGAR—
2019-03-152018-12-310001558370-19-002068EDGAR—
2018-03-072017-12-310001558370-18-001639EDGAR—
2017-03-072016-12-310001558370-17-001426EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001193125-25-262664EDGAR72K words
2025-08-042025-06-300000950170-25-102148EDGAR—
2025-05-052025-03-310000950170-25-063634EDGAR—
2024-11-122024-09-300000950170-24-124758EDGAR—
2024-08-052024-06-300000950170-24-090828EDGAR—
2024-05-062024-03-310000950170-24-053697EDGAR—
2023-11-062023-09-300000950170-23-059470EDGAR—
2023-08-072023-06-300000950170-23-039178EDGAR—
2023-05-092023-03-310000950170-23-018976EDGAR—
2022-11-072022-09-300000950170-22-022710EDGAR—
2022-08-092022-06-300000950170-22-016143EDGAR—
2022-05-022022-03-310000950170-22-006901EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-135669EDGAR1K words
2026-02-230001193125-26-062421EDGAR—
2026-02-170001193125-26-053009EDGAR—
2026-01-120001193125-26-009744EDGAR—
2025-12-310001193125-25-337644EDGAR—
2025-11-030001193125-25-261651EDGAR—
2025-08-200001579428-25-000007EDGAR—
2025-08-040000950170-25-101624EDGAR—
2025-06-100000950170-25-084098EDGAR—
2025-06-090000950170-25-083793EDGAR—

295 total filings indexed. 263 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001579428
TickerAXSM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 934c51fe43acfab8b6f7c419660dc1e20a03cdd5919884359b7693f8e888e066
parent: ff1c31764c5c8a07541ad0fcd53dbcc6bb3995afc3c887fea8bd79256eb060f1
content hash: 91a84a9614b0b0bd5a85ebeebb4c810c195f66a180b10ed7f777d72fc480a06d
signed: 2026-04-13T04:43:50.703Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf